Blueprint Medicines Corp (BPMC)
90.46
+0.13
(+0.14%)
USD |
NASDAQ |
Dec 24, 16:00
Blueprint Medicines Cash from Investing (Quarterly): 29.95M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | -348.00M |
| PTC Therapeutics Inc | -42.68M |
| Biomarin Pharmaceutical Inc | -16.16M |
| Regeneron Pharmaceuticals Inc | -574.40M |
| SpringWorks Therapeutics Inc | 28.65M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -13.64M |
| Cash from Financing (Quarterly) | 18.38M |
| Free Cash Flow | -250.52M |
| Free Cash Flow Per Share (Quarterly) | -0.2156 |
| Free Cash Flow to Equity (Quarterly) | -13.32M |
| Free Cash Flow to Firm (Quarterly) | -6.009M |
| Free Cash Flow Yield | -4.41% |